Get Started

CRIS

NASD Curis, Inc.
Nov 6, 2026 · 9:15 AM ET LAST TRADE Market Closed

$0.7700 ↓ -0.0800 (-9.41%) Trading Down from the previous close of $0.8500

YTD change
-96.10%
vs 20-day SMA
+38.42%
vs 200-day SMA
-91.13%

Price ranges

Previous day
$0.8300 $1.0900
open $1.0000 close $0.8500
-$0.1500 (-15.00%)
Today
$0.0000 $0.0000
$0.7700
Past week
$0.4677 $1.6000
from $0.5485 now $0.7700
+$0.2215 (+40.38%)
Past month
$0.3250 $1.6000
from $0.7094 now $0.7700
+$0.0606 (+8.54%)
This year
$0.1806 $19.7420
from $19.7420 now $0.7700
-$18.9720 (-96.10%)

Price & Performance

+0.23 (+37.81%) / 6M

$-0.2529$1.96$4.18$6.40May 6Aug 6Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $7,440.0000
  • CRIS is down 96% since the beginning of the year
  • CRIS is down 97% over the past 12 months
  • CRIS is up 9% over the past 1 month
  • 8% of all CRIS investors are betting against CRIS

CRIS reads poor: price sits above one of the two key moving averages, the 12-month move is -41.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-4.02
Earnings momentum -50.7% Quarterly EPS growth
Quarterly change -50.7%

Valuation

P/E ratio N/A
Enterprise value $-2757480.0
Beta 5.04

Balance sheet & scale

IncomeN/A
Revenue$4.3M
Cash$5.6M
Debt$1.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $17.2M

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $34.96 -0.40%
ARGX argenx SE Sponsored ADR $894.77 -3.93%
ONC BeOne Medicines Ltd. Sponsored ADR $387.25 +2.51%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $12.25 -1.84%
INCY Incyte Corporation $118.01 -3.94%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.